Position in AKBA
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$350,553
-$76,074 QoQ
Shares Held
307,503
+0.2% QoQ
Ownership
0.111%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#42
of 170 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 21%
Shared 0%
None 79%
Common Shares in AKBA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $455,921,156 across 48 Drug Manufacturers - Specialty & Generic names. AKBA ranks #36 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
1,437,213 | $103,278,126 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
120,078 | $65,061,862 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
312,832 | $52,724,705 | |
| 4 | VTRS |
Viatris Inc
|
2,872,464 | $45,614,728 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
1,264,159 | $31,110,952 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
|
633,778 | $21,973,083 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
197,060 | $21,861,836 | |
| 8 | ALKS |
Alkermes plc.
|
387,999 | $20,331,147 |
All Filings in AKBA
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $350,553 | 307,503 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $426,627 | 306,926 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $511,044 | 317,419 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $979,171 | 358,671 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $1,328,727 | 365,035 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $541,566 | 282,066 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $504,239 | 265,389 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $320,596 | 242,876 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $252,001 | 247,060 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $9,014 | 4,926 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $6,108 | 4,926 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $5,615 | 4,926 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $4,507 | 4,926 | Shares | Sole | 2023-08-08 | |
| 2022-03-31 | $147,234 | 205,062 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $477,119 | 211,115 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $605,692 | 210,310 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $769,214 | 202,959 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $589,805 | 174,241 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $529,426 | 189,081 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $441,800 | 176,016 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $2,840,922 | 209,199 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $1,627,357 | 214,691 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||